SRG-514

· SURGE Therapeutics

Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for SRG-514, covering 2026-02-17 to 2026-02-17. Get the full timeline:

Most recent: Clinical Trial Update: SRG-514 Administered Intraoperatively to Patients Undergoing Breast-conserving Cancer Surgery [Phase 1]